| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.35 | 4e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |